4882 Perseus Proteomics Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4882

TSE Growth

Perseus Proteomics Inc.

295

JPY

(0.00%)

Dec 5, 12:48 pm JST

1.90

USD

Dec 4, 10:48 pm EST

Result

ー

PTS

outside of trading hours

295

Dec 5, 11:29 am JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	71	-472	-481	-599	-54.5	0	May 13, 2022	J-GAAP
Mar, 2023	94	-697	-689	-786	-66.9	0	May 12, 2023	J-GAAP
Mar, 2024	100	-894	-879	-1,104	-93.7	0	May 15, 2024	J-GAAP
Mar, 2025	120	-826	-829	-904	-63.4	0	May 15, 2025	J-GAAP
Mar, 2026 Guidance	ー	ー	ー	ー	－	0	May 15, 2025	J-GAAP
YoY	－	－	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2022	Jun 22, 2021	70	-564	-583	-625	0	J-GAAP
Results	May 13, 2022	71	-472	-481	-599	0	J-GAAP
Mar, 2023	May 13, 2022	Available in future release
	Apr 25, 2023
Results	May 12, 2023
Mar, 2024	May 12, 2023
Results	May 15, 2024
Mar, 2025	May 15, 2024
	Mar 31, 2025
Results	May 15, 2025
Mar, 2026	May 15, 2025	ー	ー	ー	ー	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2015	246	－	Available in future release
Mar, 2016	570	+131.7
Mar, 2017	282	-50.5
Mar, 2018	303	+7.4
Mar, 2019	275	-9.2
Mar, 2020	85	-69.1
Mar, 2021	67	-21.2
Mar, 2022	71	+6.0
Mar, 2023	94	+32.4
Mar, 2024	100	+6.4
Mar, 2025	120	+20.0
Mar, 2026 Guidance	ー	-100.0	ー	+100.0	ー	+100.0	－	+100.0

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	100	-894	-894	-59.85	-51.84	0.05	-93.7
Mar, 2025	120	-826	-688	-67.54	-51.50	0.07	-63.4
Mar, 2026 Guidance	ー	ー	ー	ー	ー	ー	－

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	570	-144	171	154	60.4
Fiscal Year	Mar, 2016	Mar, 2019	Mar, 2016	Mar, 2016	Mar, 2016

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	47	-391	-401	-423	-36.0	0	May 12, 2023	J-GAAP
Oct - Mar, 2023	50	-450	-450	-471	-40.0	0	May 15, 2024	J-GAAP
Oct - Mar, 2024	61	-412	-402	-409	-28.7	0	May 15, 2025	J-GAAP
Oct - Mar, 2025 Guidance	ー	ー	ー	ー	－	0	May 15, 2025	J-GAAP
YoY	－	－	－	－	－

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	-697	-776	-564	-212	0	2,444	95.25	J-GAAP
Mar, 2024	-894	-983	-833	-150	63	1,541	91.02	J-GAAP
Mar, 2025	-826	-794	-719	-75	923	1,667	91.69	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2023	50	-444	-429	-633	-53.9	ー	Nov 13, 2023	J-GAAP
Apr - Sep, 2024	59	-414	-427	-495	-35.9	ー	Nov 14, 2024	J-GAAP
Apr - Sep, 2025	60	-399	-345	-379	-25.7	ー	Nov 14, 2025	J-GAAP
YoY	+1.7%	+3.6%	+19.2%	+23.4%	+28.4%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	21	-245	-253	-266	-22.6	-1,166.7	Feb 14, 2024	J-GAAP
Jan - Mar, 2024	29	-205	-197	-205	-17.4	-706.9	May 15, 2024	J-GAAP
Apr - Jun, 2024	20	-221	-214	-219	-15.8	-1,105.0	Aug 14, 2024	J-GAAP
Jul - Sep, 2024	39	-193	-213	-276	-20.0	-494.9	Nov 14, 2024	J-GAAP
Oct - Dec, 2024	24	-216	-197	-199	-14.1	-900.0	Feb 14, 2025	J-GAAP
Jan - Mar, 2025	37	-196	-205	-210	-14.7	-529.7	May 15, 2025	J-GAAP
Apr - Jun, 2025	23	-218	-171	-176	-11.9	-947.8	Aug 14, 2025	J-GAAP
Jul - Sep, 2025	37	-181	-174	-203	-13.8	-489.2	Nov 14, 2025	J-GAAP
YoY	-5.1%	+6.2%	+18.3%	+26.4%	+31.2%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2021	17	－	Available in future release
Apr - Jun, 2021	15	－
Jul - Sep, 2021	14	－
Oct - Dec, 2021	20	－
Jan - Mar, 2022	22	+29.4
Apr - Jun, 2022	25	+66.7
Jul - Sep, 2022	22	+57.1
Oct - Dec, 2022	22	+10.0
Jan - Mar, 2023	25	+13.6
Apr - Jun, 2023	24	-4.0
Jul - Sep, 2023	26	+18.2
Oct - Dec, 2023	21	-4.5
Jan - Mar, 2024	29	+16.0
Apr - Jun, 2024	20	-16.7
Jul - Sep, 2024	39	+50.0
Oct - Dec, 2024	24	+14.3
Jan - Mar, 2025	37	+27.6
Apr - Jun, 2025	23	+15.0
Jul - Sep, 2025	37	-5.1	-181	+6.2	-174	+18.3	-13.8	+31.0

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	39	-112	-109	-119	-11.1
Fiscal Year	Sep, 2024	Dec, 2021	Dec, 2021	Dec, 2021	Dec, 2021

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	201.13	92.2	2,566	2,365	-1,799	ー	May 12, 2023	J-GAAP
Mar, 2024	110.94	78.2	1,693	1,324	-2,903	ー	May 15, 2024	J-GAAP
Mar, 2025	91.74	74.4	1,818	1,353	-3,808	ー	May 15, 2025	J-GAAP
Apr - Sep, 2025	ー	66.6	1,461	973	-379	ー	Nov 14, 2025	J-GAAP

Perseus Proteomics Inc.(4882) Financial Results